The FINANCIAL — Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its portfolio of coffee, snacks and water. The Swiss owner of Nespresso will pay $34.50 a share for the U.S. biotech firm, almost triple its last closing price. Aimmune makes a therapy to help reduce allergic reactions to peanuts in children and teens by exposing them to tiny doses over time. FDA approved Aimmune Therapeutics’ Palforzia which makes it the first medication approved for food allergies in teens and children. Nestlé and Aimmune Therapeutics, Inc. a biopharmaceutical company developing and commercializing…
Read More »
The FINANCIAL — Nestle agreed to buy Aimmune Therapeutics Inc. for $2.6 billion, adding a promising peanut allergy treatment to its portfolio of coffee, snacks and water. The Swiss owner of Nespresso will pay $34.50 a share for the U.S. biotech firm, almost triple its last closing price. Aimmune makes a therapy to help reduce allergic…
You might be interested in
The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) and the Presidential Agency for International Cooperation…
Czech Republic, Romania and Croatia has the highest consumption of beer per capita in Eastern Europe
Friday 5th of August is International Beer Day. Did you know that Czech Republic, Romania and Croatia has the highest…
WASHINGTON, D.C. — When Americans are asked to name the most important problem facing the U.S., 8% of the resulting…
by Anam Rizvi — In March, Maira Omer had a summer holiday itinerary for what she described as “half of…